Baillie Gifford & CO Global Blood Therapeutics, Inc. Transaction History

Baillie Gifford & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$32.4 - $68.18 $1,846 - $3,886	57 Added 6.83%	892 $61,000
Q3 2021 Oct 19, 2021	SELL	$25.48 - $37.34 $3,032 - $4,443	-119 Reduced 12.47%	835 $21,000
Q2 2021 Aug 02, 2021	SELL	$32.46 - $43.42 $1,720 - $2,301	-53 Reduced 5.26%	954 $33,000
Q1 2021 May 06, 2021	BUY	$38.94 - $50.85 $2,219 - $2,898	57 Added 6.0%	1,007 $41,000
Q4 2020 Feb 10, 2021	BUY	$37.65 - $63.77 $35,767 - $60,581	950 New	950 $41,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.